World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 24 April 2023
Main ID:  NCT03217227
Date of registration: 11/07/2017
Prospective Registration: No
Primary sponsor: National Heart Centre Singapore
Public title: Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR EMPIRE
Scientific title: Evaluating Myocardial Ischemia in Chest Pain Using Cardiovascular Magnetic Resonance (CMR) Imaging Exercise Bike
Date of first enrolment: May 1, 2017
Target sample size: 300
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03217227
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Singapore
Contacts
Name:     Le Thu Thao, PhD
Address: 
Telephone:
Email:
Affiliation:  National Heart Research Institute Singapore
Name:     Thu Thao Le, PhD
Address: 
Telephone: 67042241
Email: le.thu.thao@nhcs.com.sg
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

Healthy Volunteers:

- 21 years and above

- Normal physical examination

- No known significant medical history

- Able to give informed consent

Patients:

- 21 years and above

- Stable angina or angina-equivalent

- Has at least one of the following risk factors:

1. Smoking

2. Diabetes (fasting glucose level > 140 mg/dL)

3. Hyperlipidemia (total cholesterol level > 250 mg/dL)

4. Abnormal ECG

5. Hypertension

Exclusion Criteria:

Healthy Volunteers:

- Contraindications to CMR implantable devices, cerebral aneurysm clips, cochlear
implants

- Claustrophobia

- Women who are pregnant

- Inability to comply with study protocol

- Not able to exercise

Patients:

- Unstable cardiac conditions that are deemed by primary investigator to be unsuitable
for this study

- Prior coronary revascularization or percutaneous coronary intervention

- Pulmonary disease

- Anemia

- Asthma

- Hyperthermia

- Hyperthyroidism

- Sympathomimetic toxicity

- Polycythemia

- Severely uncontrolled hypertension despite being on at least 3 anti-hypertensive
medications



Age minimum: 21 Years
Age maximum: 80 Years
Gender: All
Health Condition(s) or Problem(s) studied
Coronary Artery Disease
Myocardial Ischemia
Coronary Heart Disease
Cardiovascular Diseases
Ischemic Heart Disease
Microvascular Coronary Artery Disease
Intervention(s)
Other: Cardiovascular Magnetic Resonance Imaging with Exercise Bike
Other: Retinal Photography (Optional)
Diagnostic Test: I123 MIBG Scintigraphy (Optional)
Procedure: Cardiac Catheterization
Primary Outcome(s)
First occurrence of cardiovascular event [Time Frame: One year]
Secondary Outcome(s)
Secondary ID(s)
2017/2123
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history